Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient Mice
Minjee Kim(Massachusetts Eye and Ear Infirmary), William F. Elmquist(Pediatrics and Genetics), Jann N. Sarkaria(Mayo Clinic), Afroz S. Mohammad(University of Minnesota), James Fisher(University of Minnesota), Janice K. Laramy(University of Minnesota), Surabhi Talele(University of Minnesota)
Cited by 49
Related Papers
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
|Journal of Clinical Oncology|2008|275
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
|Molecular Cancer Therapeutics|2007|203
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells
|Neuro-Oncology|2012|187
The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
|Journal of Pharmacology and Experimental Therapeutics|2010|159